SEC Comment Letter 0000000000-22-012283 to 2seventy bio, Inc. (TSVT) (CIK 0001860782)
2seventy bio, Inc. (TSVT) (CIK 0001860782)
Date: Nov. 10, 2022 · CIK: 0001860782 · Accession: 0000000000-22-012283
AI Filing Summary & Sentiment
File numbers found in text: 333-268222
Letter
United States securities and exchange commission logo November 10, 2022 Nick Leschly President and Chief Executive Officer 2seventy bio, Inc. 60 Binney Street Cambridge, Massachusetts, 02142 Re:2seventy bio, Inc. Registration Statement on Form S-3 Filed November 7, 2022 File No. 333-268222 Dear Nick Leschly: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Yasin Akbari, Esq.
Show Raw Text
United States securities and exchange commission logo
November 10, 2022
Nick Leschly
President and Chief Executive Officer
2seventy bio, Inc.
60 Binney Street
Cambridge, Massachusetts, 02142
Re:2seventy bio, Inc.
Registration Statement on Form S-3
Filed November 7, 2022
File No. 333-268222
Dear Nick Leschly:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Yasin Akbari, Esq.